Learn more

LILLE TRANSFUSION SANGUINE

Overview
  • Total Patents
    14
About

LILLE TRANSFUSION SANGUINE has a total of 14 patent applications. Its first patent ever was published in 1976. It filed its patents most often in France. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are CENTRE REGIONAL DE TRANSFUSION, HESKA CORP and KM BIOLOGICS CO LTD.

Patent filings in countries

World map showing LILLE TRANSFUSION SANGUINEs patent filings in countries
# Country Total Patents
#1 France 14

Patent filings per year

Chart showing LILLE TRANSFUSION SANGUINEs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Burnouf Thierry 7
#2 Radosevich Nee 1
#3 Burnouf Epouse 1
#4 Thiebaut Jean-Marc 1
#5 Ratosevich Myriana 1
#6 Baron Michel 1
#7 Lucienne-Nee-Wartelle Mannessi 1
#8 Burnouf Miryana 1
#9 Dernis Dominique 1
#10 Broly Herve 1

Latest patents

Publication Filing date Title
FR2664165A1 Composition for stabilizing blood plasma during pasteurization.
FR2660437A1 Process for visualising erythrocyte agglutination intended for the analyses of blood compatibilities
FR2648048A1 Process for the preparation of purified albumin solutions
FR2644081A1 Liquid injection device along the interior walls of an autoclave
FR2639958A1 Biological support for cell cultures consisting of plasmatic proteins coagulated by thrombin, its use for the culture of keratinocytes, their recovery and their transport for therapeutic use
FR2632309A1 PROCESS FOR THE CHROMATOGRAPHIC PURIFICATION OF PROTEINS, PARTICULARLY FACTOR VIII, AND THE PRODUCTS OBTAINED
FR2631830A1 High purity factor ix concentrate, its preparation and its use in therapeutics
FR2622108A1 Preparation of proconvertine concentrates (factor vii), antihemophilic factor b (factor ix) and other plasma proteins, and their therapeutic use
FR2618784A1 Concentrate of thrombin-coagulable proteins, process for obtaining same and its use as a biological glue
FR2616656A1 SPRAYER OF STERILE PRODUCTS, IN PARTICULAR ASEPTIC SOLUTIONS FOR MEDICAL AND SURGICAL TREATMENTS
FR2610633A1 Process for obtaining a 1-antitrypsin concentrate from human plasma and the use thereof as a medicament